Basic Information
ID DDInter518
Drug Type small molecule
Molecular Formula C12H16F3N
Molecular Weight 231.257
CAS Number 3239-44-9
Description Dexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug. For a fairly limited time during the middle of the nineties, the US FDA had approved it for use in managing weight loss. However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn.
ATC Classification A08AA04
IUPAC Name ethyl[(2S)-1-[3-(trifluoromethyl)phenyl]propan-2-yl]amine
InChI DBGIVFWFUFKIQN-VIFPVBQESA-N
Canonical SMILES CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F
Useful Links DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Wikipedia ChEMBL ZINC
Interactions with Dexfenfluramine
Filter:
Severity level ID Name Mechanism Detail
Interactions with diseases
Filter:
Severity level Disease name Text References
Interactions with foods
Filter:
Severity level Food name Description Management Mechanism References
Interactions with compound preparation
Multi-DRUG trade Multi-DRUG Drug type Warning Note